For more than two millennia, mathematicians have produced a growing heap of pi equations in their ongoing search for methods to calculate pi faster and faster. The pile of equatio ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Staff ReporterMuscat, March 12Among the many innovative research projects recognised at the 12th National Research Award ...
The director of the National Institutes of Health and interim director of the U.S. Centers for Disease Control, Dr. Jay Bhattacharya, said he's concerned about the growing disconnect between ...
First real-world validation of China’s YDHB-NS01 shows 100% success, shorter procedures than manual angiography, and no ...
Autoimmune and autoinflammatory diseases are distinct but related categories of disorders characterized by an abnormal immune response. While autoimmune diseases involve adaptive immunity and the ...
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.
Our mission is to provide the fullest possible accounting for our missing personnel to their families and the nation," Col. Derek Rankin said.
YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...
Introduction Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application.
Business Insider Africa on MSN
Meet Dr. Ibi Max‑Harry, the Nigerian scientist using AI and molecular biology to transform diabetes research and STEM education at MIT
When Dr. Ibiagbani “Ibi” Max‑Harry was eight, she first understood that the world could be larger than the classroom she knew. Her mother, a chemical engineer and lecturer, had just left for the ...
The director of the National Institutes of Health and interim director of the CDC, Dr. Jay Bhattacharya, said he's concerned about the growing disconnect between scientists and the public .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results